Uploaded May 2026 | Updated September 2026, 2 weeks ago
What is driving long-term opportunity in longevity science and AI-driven healthcare - and where does Deep Longevity fit into that picture?
This session explores Deep Longevity’s role in advancing ageing research through artificial intelligence, and how structural trends like preventative healthcare, biomarker discovery, and personalised medicine are shaping its outlook.
What you’ll learn:
• Why longevity science is becoming increasingly data- and AI-driven
• Deep Longevity’s platform, technology, and commercial strategy
• Key drivers: ageing populations, preventative healthcare, and biomarker-based insights
• The role of AI in extending healthspan and improving healthcare outcomes
• Risks investors should consider in emerging biotech and longevity-focused companies
Featuring:
Deepankar Nayak – Deep Longevity
About this session:
Recorded live at the Master Investor Show, the UK’s leading event for private investors.
👇 Enjoyed this video?
👍 Like & subscribe for more investor insights
💬 Comment below: Do you think longevity and AI-driven healthcare will become a major investment theme?
🔗 Resources & Links:
masterinvestorshow.co.uk
deeplongevity.com
Keep in touch:
Substack | masterinvestoruk.substack.com
Newsletter | masterinvestor.co.uk/subscribe
Twitter | / masterinvestor
Facebook | / masterinvestor
LinkedIn | / masterinvestor
TikTok | / masterinvestoruk
#Investing #Longevity #HealthTech #AI #Biotech #PreventativeHealthcare #FutureOfHealth #GrowthStocks
What is driving long-term opportunity in longevity science and AI-driven healthcare - and where does Deep Longevity fit into that picture?
This session explores Deep Longevity’s role in advancing ageing research through artificial intelligence, and how structural trends like preventative healthcare, biomarker discovery, and personalised medicine are shaping its outlook.
What you’ll learn:
• Why longevity science is becoming increasingly data- and AI-driven
• Deep Longevity’s platform, technology, and commercial strategy
• Key drivers: ageing populations, preventative healthcare, and biomarker-based insights
• The role of AI in extending healthspan and improving healthcare outcomes
• Risks investors should consider in emerging biotech and longevity-focused companies
Featuring:
Deepankar Nayak – Deep Longevity
About this session:
Recorded live at the Master Investor Show, the UK’s leading event for private investors.
👇 Enjoyed this video?
👍 Like & subscribe for more investor insights
💬 Comment below: Do you think longevity and AI-driven healthcare will become a major investment theme?
🔗 Resources & Links:
masterinvestorshow.co.uk
deeplongevity.com
Keep in touch:
Substack | masterinvestoruk.substack.com
Newsletter | masterinvestor.co.uk/subscribe
Twitter | / masterinvestor
Facebook | / masterinvestor
LinkedIn | / masterinvestor
TikTok | / masterinvestoruk
#Investing #Longevity #HealthTech #AI #Biotech #PreventativeHealthcare #FutureOfHealth #GrowthStocks



https://solomon-global.com
Keep in touch:
Substack | [Master Investor Substack](https://masterinvestoruk.substack.com?utm_source=chatgpt.com)
Newsletter | [Master Investor Newsletter](https://masterinvestor.co.uk/subscribe?utm_source=chatgpt.com)
Twitter | / masterinvestor
Facebook | / masterinvestor
LinkedIn | / masterinvestor
TikTok | / masterinvestoruk
#Investing #Gold #Silver #WealthPreservation #Inflation #SafeHaven #PreciousMetals #UKInvesting Why Investors Are Buying Physical Gold & Silver Again in 2026](https://i.ytimg.com/vi/HzevALArMas/mqdefault.jpg)







